Promino Announces Closing of Private Placement

Core Viewpoint - Promino Nutritional Sciences Inc. has successfully closed a private placement, raising a total of $1,121,413 by issuing 37,380,433 units at a price of $0.03 per unit, with each unit consisting of one common share and one warrant [1][4] Group 1: Private Placement Details - The private placement involved the issuance of 37,380,433 units at $0.03 per unit, resulting in gross proceeds of $1,121,413 [1] - The company paid finders' fees of $69,233 in cash and issued 2,307,767 finders warrants, each exercisable at $0.06 for twelve months [2] - Upon closing, AlphaNorth Partners Fund Inc. increased its ownership from approximately 8.78% to 10.71%, holding 18,824,851 shares [3] Group 2: Use of Proceeds - Net proceeds from the private placement will be allocated to accelerate growth through inventory investments and for general corporate purposes, excluding salaries for officers or directors [4] Group 3: Company Overview - Promino Nutritional Sciences is focused on science-based nutrition for muscle health, with its core product being Rejuvenate Muscle Health™, a clinically researched amino acid formula [5] - The company also produces Promino™, which is NSF Certified for Sport® and endorsed by elite athletes [6]